A detailed history of Dg Capital Management, LLC transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Dg Capital Management, LLC holds 5,115,747 shares of AMRN stock, worth $3.07 Million. This represents 1.36% of its overall portfolio holdings.

Number of Shares
5,115,747
Previous 6,444,743 20.62%
Holding current value
$3.07 Million
Previous $5.74 Million 38.47%
% of portfolio
1.36%
Previous 3.54%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$0.63 - $1.07 $837,267 - $1.42 Million
-1,328,996 Reduced 20.62%
5,115,747 $3.53 Million
Q1 2024

May 14, 2024

BUY
$0.82 - $1.35 $852,230 - $1.4 Million
1,039,305 Added 19.23%
6,444,743 $5.74 Million
Q4 2023

Feb 12, 2024

SELL
$0.66 - $0.91 $210,747 - $290,576
-319,315 Reduced 5.58%
5,405,438 $4.7 Million
Q3 2023

Nov 14, 2023

BUY
$0.85 - $1.43 $212,500 - $357,500
250,000 Added 4.57%
5,724,753 $5.27 Million
Q1 2023

May 11, 2023

SELL
$1.19 - $2.19 $398,291 - $732,990
-334,699 Reduced 5.76%
5,474,753 $8.21 Million
Q2 2022

Aug 12, 2022

BUY
$1.13 - $3.69 $1.66 Million - $5.41 Million
1,464,967 Added 33.72%
5,809,452 $8.66 Million
Q4 2021

Feb 14, 2022

BUY
$3.24 - $5.18 $1.05 Million - $1.69 Million
325,615 Added 8.1%
4,344,485 $14.6 Million
Q3 2021

Nov 12, 2021

SELL
$3.94 - $5.84 $1.24 Million - $1.83 Million
-313,613 Reduced 7.24%
4,018,870 $20.5 Million
Q2 2021

Aug 12, 2021

BUY
$4.26 - $6.5 $4.92 Million - $7.51 Million
1,155,337 Added 36.36%
4,332,483 $19 Million
Q1 2021

May 13, 2021

BUY
$5.03 - $8.8 $4.81 Million - $8.41 Million
955,693 Added 43.02%
3,177,146 $19.7 Million
Q4 2020

Feb 12, 2021

BUY
$4.04 - $5.31 $8.97 Million - $11.8 Million
2,221,453 New
2,221,453 $10.9 Million

Others Institutions Holding AMRN

About AMARIN CORP PLCUK


  • Ticker AMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 403,206,016
  • Market Cap $242M
  • Description
  • Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...
More about AMRN
Track This Portfolio

Track Dg Capital Management, LLC Portfolio

Follow Dg Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dg Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dg Capital Management, LLC with notifications on news.